Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical TrialHong Yang, Jiaming Wang, Qingsong Pang et al.|Journal of Clinical Oncology|2018Cited by 976
SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinomaYu-Feng Yang, Hong Yang|Molecular Cancer|2018Cited by 137
The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinomaYihong Ling, Jing Wen, Jian Zhong et al.|Clinical and Translational Medicine|2022Cited by 85
Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinomaGuozhen Yang, Xu Zhang, Xiaodong Su et al.|Annals of Translational Medicine|2021Cited by 54
Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinomaHong Yang, Yan Li|Oncotarget|2015Cited by 47